138 related articles for article (PubMed ID: 24913567)
1. miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway.
Kang S; Zhao Y; Hu K; Xu C; Wang L; Liu J; Yao A; Zhang H; Cao F
Prostate; 2014 Aug; 74(11):1095-106. PubMed ID: 24913567
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
3. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
4. PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways.
Yao Z; Sun B; Hong Q; Yan J; Mu D; Li J; Sheng H; Guo H
Drug Des Devel Ther; 2015; 9():5911-23. PubMed ID: 26604689
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
Yuasa K; Suzue K; Nagahama M; Matsuda Y; Tsuji A
Gene; 2007 Nov; 402(1-2):103-10. PubMed ID: 17825503
[TBL] [Abstract][Full Text] [Related]
6. Role of proprotein convertases in prostate cancer progression.
Couture F; D'Anjou F; Desjardins R; Boudreau F; Day R
Neoplasia; 2012 Nov; 14(11):1032-42. PubMed ID: 23226097
[TBL] [Abstract][Full Text] [Related]
7. Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells.
D'Anjou F; Couture F; Desjardins R; Day R
Methods Mol Biol; 2014; 1103():67-82. PubMed ID: 24318887
[TBL] [Abstract][Full Text] [Related]
8. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Page RE; Klein-Szanto AJ; Litwin S; Nicolas E; Al-Jumaily R; Alexander P; Godwin AK; Ross EA; Schilder RJ; Bassi DE
Cell Oncol; 2007; 29(4):289-99. PubMed ID: 17641413
[TBL] [Abstract][Full Text] [Related]
10. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors.
Bakrania A; Aubé M; Desjardins R; Sabbagh R; Day R
Can J Physiol Pharmacol; 2020 Jul; 98(7):477-481. PubMed ID: 32119574
[TBL] [Abstract][Full Text] [Related]
12. Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium.
Freyer C; Kilpatrick LM; Salamonsen LA; Nie G
Reproduction; 2007 Jun; 133(6):1189-97. PubMed ID: 17636173
[TBL] [Abstract][Full Text] [Related]
13. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
[TBL] [Abstract][Full Text] [Related]
15. Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
Dianati V; Kwiatkowska A; Couture F; Desjardins R; Dory YL; Day R
J Med Chem; 2018 Sep; 61(18):8457-8467. PubMed ID: 30180568
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J
Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210
[TBL] [Abstract][Full Text] [Related]
17. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
Kong X; Qian X; Duan L; Liu H; Zhu Y; Qi J
DNA Cell Biol; 2016 Dec; 35(12):828-835. PubMed ID: 27673408
[TBL] [Abstract][Full Text] [Related]
18. Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
Małuch I; Levesque C; Kwiatkowska A; Couture F; Ly K; Desjardins R; Neugebauer WA; Prahl A; Day R
J Med Chem; 2017 Apr; 60(7):2732-2744. PubMed ID: 28287731
[TBL] [Abstract][Full Text] [Related]
19. PACE4 regulates apoptosis in human pancreatic cancer Panc‑1 cells via the mitochondrial signaling pathway.
Tian XF; Huang GM; Zang HL; Cao H
Mol Med Rep; 2016 Dec; 14(6):5205-5210. PubMed ID: 27779720
[TBL] [Abstract][Full Text] [Related]
20. PACE4-altCT isoform of proprotein convertase PACE4 as tissue and plasmatic biomarker for prostate cancer.
Couture F; Wang L; Dufour F; Chabot-Maheux K; Ekindi Ndongo N; Sabbagh R; Day R
Sci Rep; 2022 Apr; 12(1):6066. PubMed ID: 35410344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
